|
|
|
|
Niemann-Pick disease
|
| |
|
| |
Niemann-Pick disease (pronounced ne'mahn pik) refers to a group of fatal inherited metabolic disorders that are included in the larger family of lysosomal storage diseases (LSDs).
ann-Pick diseases are classified in a subgroup of LSDs called sphingolipidoses or lipid storage disorders in which harmful quantities of a fatty substances, called lipids, accumulate in the spleen, liver, lungs, bone marrow, and brain. Histology demonstrates lipid laden macrophages in the marrow, as well as "sea-blue histiocytes" on pathology.
toms are related to the organs in which they accumulate.

Discussion
Ask a question about 'Niemann-Pick disease'
Start a new discussion about 'Niemann-Pick disease'
Answer questions from other users
|
Encyclopedia
Niemann-Pick disease (pronounced ne'mahn pik) refers to a group of fatal inherited metabolic disorders that are included in the larger family of lysosomal storage diseases (LSDs).
Pathophysiology
Niemann-Pick diseases are classified in a subgroup of LSDs called sphingolipidoses or lipid storage disorders in which harmful quantities of a fatty substances, called lipids, accumulate in the spleen, liver, lungs, bone marrow, and brain. Histology demonstrates lipid laden macrophages in the marrow, as well as "sea-blue histiocytes" on pathology.
Presentation
Symptoms are related to the organs in which they accumulate. Enlargement of the liver and spleen (hepatosplenomegaly) may cause reduced appetite, abdominal distension and pain as well as thrombocytopenia secondary to splenomegaly.
Sphingomyelinase accumulation in the central nervous system (including the cerebellum) results in unsteady gait (ataxia), slurring of speech (dysarthria) and discoordinated swallowing (dysphagia). Basal ganglia dysfunction causes abnormal posturing of the limbs, trunk and face (dystonia) and upper brainstem disease results in impaired voluntary rapid eye movements (supranuclear gaze palsy). More widespread disease involving the cerebral cortex and subcortical structures is responsible for gradual loss of intellectual abilities causing dementia and seizures.
Sleep related disorders are also seen, including gelastic cataplexy (sudden loss of muscle tone associated with laughter), and sleep inversion (sleepiness during the day and wakefulness at night).
Treatment
No specific treatment is available for Niemann-Pick with care being mostly supportive. Anecdotally, organ transplant has been attempted with limited success. Future prospects include enzyme replacement and gene therapy. There is variable severity of presentation seen with patients in the most severe subtypes having an average life expectancy of two years. bone marrow transplant has been attempted for type B. C & D are usually on a low cholesterol diet. supportive care through nutrition, medication, physical therapy and being followed by specialists can help with quality of life.
History
Albert Niemann published the first description of what is now known as Niemann-Pick disease, type A, in 1914. Luddwick Pick described the pathology of the disease in a series of papers in the 1930s.
Genetics
Mutations in the SMPD1 gene cause Niemann-Pick disease types A and B, and mutations in NPC1 and NPC2 cause Niemann-Pick disease, type C (NPC). Type D was originally separated from Type C to delineate a group of patients with otherwise identical disorders who shared a common Nova Scotian ancestry. Patients in this group are now known to share a specific mutation in the NPC 1 gene, and NPC is now used to embrace both groups. The terms "Niemann-Pick type I" and "Niemann-Pick type II" were proposed to separate the high and low sphingomyelin forms of the disease in the early 1980s, before the molecular defects were described.
Niemann-Pick disease is inherited in an autosomal recessive pattern, which means both copies, or alleles, of the gene must be mutated (altered in such a way that function is impaired, in contrast to a polymorphism, in which the nucleotide sequence is altered but causes no functional disruption) for a person to be affected by the disorder. Most often, the parents of a child with an autosomal recessive disorder are not affected but are carriers of one copy of the altered gene. If both parents are carriers, there is a 25% chance with each pregnancy for an affected child. Genetic counseling and genetic testing is recommended for families who may be carriers of Niemann-Pick.
Classification
In 1961, the following classification was introduced:
- Niemann-Pick disease type A: classic infantile
- Niemann-Pick disease type B: visceral
- Niemann-Pick disease, type C: subacute/juvenile
- Niemann-Pick disease type D: Nova Scotian
Now that the genetics are better understood, the condition can be classified as follows:
External links
|
| |
|
|